382 related articles for article (PubMed ID: 19672101)
1. Human parvovirus B19 (B19V) infection in systemic sclerosis patients.
Zakrzewska K; Corcioli F; Carlsen KM; Giuggioli D; Fanci R; Rinieri A; Ferri C; Azzi A
Intervirology; 2009; 52(5):279-82. PubMed ID: 19672101
[TBL] [Abstract][Full Text] [Related]
2. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
3. High frequency of parvovirus B19 DNA in bone marrow samples from rheumatic patients.
Lundqvist A; Isa A; Tolfvenstam T; Kvist G; Broliden K
J Clin Virol; 2005 May; 33(1):71-4. PubMed ID: 15797368
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis.
Kuethe F; Lindner J; Matschke K; Wenzel JJ; Norja P; Ploetze K; Schaal S; Kamvissi V; Bornstein SR; Schwanebeck U; Modrow S
Clin Infect Dis; 2009 Dec; 49(11):1660-6. PubMed ID: 19863443
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
6. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons.
Corcioli F; Zakrzewska K; Rinieri A; Fanci R; Innocenti M; Civinini R; De Giorgi V; Di Lollo S; Azzi A
J Med Virol; 2008 Nov; 80(11):2005-11. PubMed ID: 18814251
[TBL] [Abstract][Full Text] [Related]
7. Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia.
Plentz A; Würdinger M; Kudlich M; Modrow S
J Clin Virol; 2013 Oct; 58(2):443-8. PubMed ID: 23916377
[TBL] [Abstract][Full Text] [Related]
8. Evidence for persistence of human parvovirus B19 DNA in bone marrow.
Cassinotti P; Burtonboy G; Fopp M; Siegl G
J Med Virol; 1997 Nov; 53(3):229-32. PubMed ID: 9365887
[TBL] [Abstract][Full Text] [Related]
9. Parvovirus B19 infection of bone marrow in systemic sclerosis patients.
Ferri C; Zakrzewska K; Longombardo G; Giuggioli D; Storino FA; Pasero G; Azzi A
Clin Exp Rheumatol; 1999; 17(6):718-20. PubMed ID: 10609071
[TBL] [Abstract][Full Text] [Related]
10. Impact of parvovirus B19 infection on paediatric patients with haematological and/or oncological disorders.
Jitschin R; Peters O; Plentz A; Turowski P; Segerer H; Modrow S
Clin Microbiol Infect; 2011 Sep; 17(9):1336-42. PubMed ID: 20825443
[TBL] [Abstract][Full Text] [Related]
11. Adaptive immune responses against parvovirus B19 in patients with myocardial disease.
Lindner J; Noutsias M; Lassner D; Wenzel J; Schultheiss HP; Kuehl U; Modrow S
J Clin Virol; 2009 Jan; 44(1):27-32. PubMed ID: 18980860
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic long-term persistence of parvovirus B19 and its role in chronic viral hepatitis.
Wang C; Heim A; Schlaphoff V; Suneetha PV; Stegmann KA; Jiang H; Krueger M; Fytili P; Schulz T; Cornberg M; Kandolf R; Manns MP; Bock CT; Wedemeyer H
J Med Virol; 2009 Dec; 81(12):2079-88. PubMed ID: 19856479
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of acute infection with parvovirus B19 genotype 2 in immunocompromised patients in Poland.
Grabarczyk P; Kalińska A; Kara M; Wieczorek R; Ejduk A; Sulkowska E; Gołębiowska-Staroszczyk S; Matysiak M; Baylis SA; Brojer E
J Med Virol; 2011 Jan; 83(1):142-9. PubMed ID: 21108352
[TBL] [Abstract][Full Text] [Related]
14. Low level myocardial parvovirus B19 persistence is a frequent finding in patients with heart disease but unrelated to ongoing myocardial injury.
Lotze U; Egerer R; Glück B; Zell R; Sigusch H; Erhardt C; Heim A; Kandolf R; Bock T; Wutzler P; Figulla HR
J Med Virol; 2010 Aug; 82(8):1449-57. PubMed ID: 20572082
[TBL] [Abstract][Full Text] [Related]
15. Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.
Escher F; Modrow S; Sabi T; Kühl U; Lassner D; Schultheiss HP; Noutsias M
Med Sci Monit; 2008 Dec; 14(12):CR589-97. PubMed ID: 19043365
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
18. Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan.
Chen YS; Chou PH; Li SN; Tsai WC; Lin KH; Tsai KB; Yen JH; Liu HW
J Rheumatol; 2006 May; 33(5):887-91. PubMed ID: 16511938
[TBL] [Abstract][Full Text] [Related]
19. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States.
Rinckel LA; Buno BR; Gierman TM; Lee DC
Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024
[TBL] [Abstract][Full Text] [Related]
20. Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and β-thalassemia major and healthy blood donors.
Slavov SN; Haddad SK; Silva-Pinto AC; Amarilla AA; Alfonso HL; Aquino VH; Covas DT
J Med Virol; 2012 Oct; 84(10):1652-65. PubMed ID: 22930515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
